We are specializing in the development, integration and commercialization of Life Science technologies
Goldman Bio is dedicated to advancing Israeli technologies that will improve the quality of life and the life expectancy of cancer patients.
We provide a powerful and proficient infrastructure for the development, integration and commercialization of Israeli cancer research technologies whilst achieving significant economic value on behalf of our stakeholders.
Direct access to knowledge sources; universities, research institutes, clinical research departments and private enterprise.
Ability to select and evaluate breakthrough technologies in the group’s focus fields.
Integration of leading scientific experts and consultants in the R&D and management process.
International collaboration with key players active in the specific fields to enhance the R&D and promote the projects.
Precise management methodologies linked to objectives.
IT infrastructure that provides full transparency to the investors, managers and partners.
A structured process for technology commercialization.
Knowledge sharing platforms and unified management tools, producing synergies and added value to the portfolio companies.
A balanced portfolio continuously generating attractive returns for the investors and inventors